# Mays J W Inc: overview MAYS · Nasdaq · CIK 54187 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jul 31 Pages: [Overview](/companies/mays.md) · [Financials](/companies/mays/financials.md) · [Filings](/companies/mays/filings.md) · [Insiders](/companies/mays/insiders.md) Latest reported revenue: [$5.3m](/filings/0001206774-26-000322.md) for Q3 FY2026, three months to 2026-04-30, from the 10-Q filed Jun 11, 2026 (XBRL us-gaap:Revenues, accession 0001206774-26-000322). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [5,490 d](/filings/0001206774-25-000720.md) | [5,539](/filings/0001206774-25-000765.md) | [5,643](/filings/0001206774-26-000137.md) | [5,632](/filings/0001206774-26-000322.md) | [5,655 d](/filings/0001206774-25-000720.md) | [5,251](/filings/0001206774-25-000765.md) | [5,211](/filings/0001206774-26-000137.md) | [5,315](/filings/0001206774-26-000322.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(1.5%) d](/filings/0001206774-25-000720.md) | [0.9%](/filings/0001206774-25-000765.md) | [(3.2%)](/filings/0001206774-26-000137.md) | [2.0%](/filings/0001206774-26-000322.md) | [(2.4%) d](/filings/0001206774-25-000720.md) | [(9.3%)](/filings/0001206774-25-000765.md) | [(13.7%)](/filings/0001206774-26-000137.md) | [(6.1%)](/filings/0001206774-26-000322.md) | | Net margin | % | [(0.6%) d](/filings/0001206774-25-000720.md) | [0.5%](/filings/0001206774-25-000765.md) | [(2.8%)](/filings/0001206774-26-000137.md) | [1.5%](/filings/0001206774-26-000322.md) | [(1.6%) d](/filings/0001206774-25-000720.md) | [(6.4%)](/filings/0001206774-25-000765.md) | [(9.8%)](/filings/0001206774-26-000137.md) | [(4.1%)](/filings/0001206774-26-000322.md) | | Diluted EPS | $ per share | not reported | [0.01](/filings/0001206774-25-000765.md) | [(0.08)](/filings/0001206774-26-000137.md) | [0.04](/filings/0001206774-26-000322.md) | not reported | [(0.17)](/filings/0001206774-25-000765.md) | [(0.25)](/filings/0001206774-26-000137.md) | [(0.11)](/filings/0001206774-26-000322.md) | | Free cash flow | $k | [(1,839) d](/filings/0001206774-25-000720.md) | [1,343](/filings/0001206774-25-000765.md) | [(586) d](/filings/0001206774-26-000137.md) | [868 d](/filings/0001206774-26-000322.md) | [(1,496) d](/filings/0001206774-25-000720.md) | [1,511](/filings/0001206774-25-000765.md) | [(1,714) d](/filings/0001206774-26-000137.md) | [(1,309) d](/filings/0001206774-26-000322.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-07-31) | FY2022 (2022-07-31) | FY2023 (2023-07-31) | FY2024 (2024-07-31) | FY2025 (2025-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [20.2](/filings/0001206774-22-002558.md) | [21.4](/filings/0001206774-23-001194.md) | [22.6](/filings/0001206774-24-000954.md) | [21.6](/filings/0001206774-25-000720.md) | [22.5](/filings/0001206774-25-000720.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(4.1%)](/filings/0001206774-22-002558.md) | [(3.1%)](/filings/0001206774-23-001194.md) | [1.0%](/filings/0001206774-24-000954.md) | [(2.9%)](/filings/0001206774-25-000720.md) | [(0.7%)](/filings/0001206774-25-000720.md) | | Net margin | % | [2.0%](/filings/0001206774-22-002558.md) | [(3.3%)](/filings/0001206774-23-001194.md) | [(0.4%)](/filings/0001206774-24-000954.md) | [(1.9%)](/filings/0001206774-25-000720.md) | [(0.6%)](/filings/0001206774-25-000720.md) | | Diluted EPS | $ per share | not reported | [(0.35)](/filings/0001206774-23-001194.md) | [(0.04)](/filings/0001206774-24-000954.md) | [(0.20)](/filings/0001206774-25-000720.md) | [(0.07)](/filings/0001206774-25-000720.md) | | Free cash flow | $m | [(1.2)](/filings/0001206774-22-002558.md) | [(0.0)](/filings/0001206774-23-001194.md) | [1.2](/filings/0001206774-24-000954.md) | [(1.0)](/filings/0001206774-25-000720.md) | [0.1](/filings/0001206774-25-000720.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mays/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $1.7m | 44,431 | | Unchanged | | [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $1.7m | 44,431 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $342.7k | 8,786 | | Added +292 | | [Next Capital Management LLC](/funds/1752762.md) | 2026-06-30 | $285.7k | 7,326 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $247.2k | 6,338 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $145.5k | 3,730 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $38.2k | 980 | | Added +95 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.0k | 385 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $4.1k | 105 | | Reduced −97 | | [Cheviot Value Management, LLC](/funds/1427147.md) | 2026-06-30 | $936 | 24 | | Unchanged | ## Recent filings [All 238 filings](/companies/mays/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 13:37 ET | [8-K](/filings/0001206774-26-000575.md) | 2.02 Results of operations | 0001206774-26-000575 | | 2026-10-22 | 13:31 ET | [DEF 14A](/filings/0001206774-26-000573.md) | Proxy statement, period 2026-11-24 | 0001206774-26-000573 | | 2026-10-22 | 13:28 ET | [10-K](/filings/0001206774-26-000572.md) | Annual report, period 2026-07-31 | 0001206774-26-000572 | | 2026-10-15 | 11:00 ET | [8-K](/filings/0001206774-26-000561.md) | 5.02 Departure or appointment of officers or directors | 0001206774-26-000561 | | 2026-07-31 | 22:02 ET | [8-K](/filings/0001206774-26-000392.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001206774-26-000392 | | 2026-06-11 | 12:05 ET | [8-K](/filings/0001206774-26-000323.md) | 2.02 Results of operations | 0001206774-26-000323 | | 2026-06-11 | 12:01 ET | [10-Q](/filings/0001206774-26-000322.md) | Quarterly report, period 2026-04-30 | 0001206774-26-000322 | | 2026-05-15 | 20:16 ET | [8-K](/filings/0001206774-26-000284.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001206774-26-000284 | | 2026-04-15 | 10:30 ET | [8-K/A](/filings/0001206774-26-000218.md) | 7.01 Regulation FD disclosure | 0001206774-26-000218 | | 2026-04-14 | 20:10 ET | [8-K](/filings/0001206774-26-000210.md) | 7.01 Regulation FD disclosure | 0001206774-26-000210 | ## Latest annual report [Form 10-K for the fiscal year ended Jul 31, 2026](/filings/0001206774-26-000572.md), filed Oct 22, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 54187 - Tickers: MAYS - Exchange: Nasdaq - SIC code: 6512 Opeators of Nonresidential Buildings - State of incorporation: NY - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.